These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38744461)

  • 21. Electrophysiological studies in the different genotypes of Charcot-Marie-Tooth disease.
    England JD; Garcia CA
    Curr Opin Neurol; 1996 Oct; 9(5):338-42. PubMed ID: 8894408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetic convergence of Charcot-Marie-Tooth disease types 1 and 2 and the role of genetics in sporadic neuropathy.
    Boerkoel CF; Takashima H; Lupski JR
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):70-7. PubMed ID: 11898586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.
    Saporta MA; Katona I; Lewis RA; Masse S; Shy ME; Li J
    Brain; 2009 Dec; 132(Pt 12):3263-73. PubMed ID: 19923170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.
    Hines TJ; Tadenev ALD; Lone MA; Hatton CL; Bagasrawala I; Stum MG; Miers KE; Hornemann T; Burgess RW
    J Anat; 2022 Nov; 241(5):1169-1185. PubMed ID: 34875719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Charcot-Marie-Tooth disease: an update.
    Shy ME
    Curr Opin Neurol; 2004 Oct; 17(5):579-85. PubMed ID: 15367862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease.
    Hertzog N; Jacob C
    Neural Regen Res; 2023 Sep; 18(9):1931-1939. PubMed ID: 36926710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-Marie-Tooth disease type 4.
    Claramunt R; Sevilla T; Lupo V; Cuesta A; Millán JM; Vílchez JJ; Palau F; Espinós C
    Clin Genet; 2007 Apr; 71(4):343-9. PubMed ID: 17470135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pooled European series of hereditary peripheral neuropathies in infancy and childhood. A "correspondence work shop" report of the European Federation of Child Neurology Societies (EFCNS).
    Hagberg B; Lyon G
    Neuropediatrics; 1981 Feb; 12(1):9-17. PubMed ID: 6265822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unilateral oculomotor palsy in Charcot-Marie-Tooth disease 1A (CMT 1A).
    Posa A; Emmer A; Kornhuber ME
    Clin Neurol Neurosurg; 2017 Apr; 155():20-21. PubMed ID: 28214652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.
    Stavrou M; Sargiannidou I; Georgiou E; Kagiava A; Kleopa KA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Charcot-Marie-Tooth neuropathies.
    Beloribi-Djefaflia S; Attarian S
    Rev Neurol (Paris); 2023; 179(1-2):35-48. PubMed ID: 36588067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A National French Consensus on Gene List for the Diagnosis of Charcot-Marie-Tooth Disease and Related Disorders Using Next-Generation Sequencing.
    Benquey T; Pion E; Cossée M; Krahn M; Stojkovic T; Perrin A; Cerino M; Molon A; Lia AS; Magdelaine C; Francou B; Guiochon-Mantel A; Malinge MC; Leguern E; Lévy N; Attarian S; Latour P; Bonello-Palot N
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary neuropathies.
    Berciano J; Combarros O
    Curr Opin Neurol; 2003 Oct; 16(5):613-22. PubMed ID: 14501846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Charcot-Marie-Tooth neuropathies and related disorders.
    Mendell JR
    Semin Neurol; 1998; 18(1):41-7. PubMed ID: 9562666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.
    Montecchiani C; Pedace L; Lo Giudice T; Casella A; Mearini M; Gaudiello F; Pedroso JL; Terracciano C; Caltagirone C; Massa R; St George-Hyslop PH; Barsottini OG; Kawarai T; Orlacchio A
    Brain; 2016 Jan; 139(Pt 1):73-85. PubMed ID: 26556829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin.
    Auer-Grumbach M; Weger M; Fink-Puches R; Papić L; Fröhlich E; Auer-Grumbach P; El Shabrawi-Caelen L; Schabhüttl M; Windpassinger C; Senderek J; Budka H; Trajanoski S; Janecke AR; Haas A; Metze D; Pieber TR; Guelly C
    Brain; 2011 Jun; 134(Pt 6):1839-52. PubMed ID: 21576112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Charcot-Marie-Tooth disease and intracellular traffic.
    Bucci C; Bakke O; Progida C
    Prog Neurobiol; 2012 Dec; 99(3):191-225. PubMed ID: 22465036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options in Charcot-Marie-Tooth diseases.
    Mathis S; Magy L; Vallat JM
    Expert Rev Neurother; 2015 Apr; 15(4):355-66. PubMed ID: 25703094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A.
    Yoshikawa H; Nishimura T; Nakatsuji Y; Fujimura H; Himoro M; Hayasaka K; Sakoda S; Yanagihara T
    Ann Neurol; 1994 Apr; 35(4):445-50. PubMed ID: 7512319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development.
    Juneja M; Burns J; Saporta MA; Timmerman V
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):58-67. PubMed ID: 30018047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.